SiSU Health, a Manchester-based digital health platform focused on prevention and early intervention, has raised £1.25 million from Praetura Ventures to scale its reach and operations across the UK and Europe.
The funding comes from the GMC Life Sciences Fund By Praetura — backed by Bruntwood SciTech, Greater Manchester Combined Authority, and Enterprise Cheshire and Warrington — along with NPIF II – Praetura Equity Finance. This marks the fifth co-investment between the two funds in the past year.
SiSU Health enables early detection of risk factors such as high blood pressure and obesity and has already supported nearly 20,000 people a month through its platform. The business aims to deploy over 600 self-service health stations in workplaces, NHS settings, and community locations by 2026.
Its Health Station allows users to complete a fully digital health check in around five minutes, with results accessed via a companion platform that supports follow-on care. The system integrates with local health pathways, combining behavioural science, technology, and data analytics to support population health and reduce pressure on NHS services.
The business is expanding its manufacturing operations in Manchester and working with the Department for Business & Trade to source a larger facility.
With over one million health checks delivered to date, SiSU’s data shows that over 70% of users had not had a recent blood pressure test — highlighting the importance of accessible preventative tools. SiSU works with clients including Aldi, Jaguar Land Rover, The AA, and NHS Trusts, and played a key role in the Department of Health and Social Care’s CVD Workforce Health Check Programme.
We’re building a future where everyone has the tools and confidence to take control of their health — wherever they are. This funding allows us to scale our digital platform, extend our reach into new communities, and strengthen our collaborations and integrations across employer, public health and primary care. Prevention has to be proactive, accessible and data-informed — and that’s exactly what SiSU Health delivers.
Samantha Fay, CEO
SiSU Health is bringing health into the modern age by helping individuals to take a health test at a time that’s convenient to them without judgement and the costs that can be associated with health checks. They are critically providing connected collaboration between the corporate world and public health systems, encouraging self-care and health awareness for individuals with supported follow-up and interventions, which has significant benefits for the NHS and public health.
Sim Singh-Landa, Investor at Praetura
The GMC Life Sciences Fund By Praetura was set up to grow the region’s life sciences footprint to new levels of widespread recognition and give support to innovative businesses like SiSU Health who are tackling challenges like public health and the need to reach underrepresented demographics. We’re looking forward to seeing what the future holds for the SiSU Health team, as they scale the business’s manufacturing and logistics output from right here in the North West.
Dr Kath Mackay, Chief Scientific Officer at Bruntwood SciTech
A key aim of the Northern Powerhouse Investment Fund II is to invest in businesses that are paving the way in innovation and creating valuable solutions for the people it serves. It’s clear that the UK needs new solutions for healthcare issues and now, with the help of NPIF II funding, another great Northern business has secured the financial support it needs to help make this possible.
Sue Barnard, Investor at British Business Bank
